Username Password
S&P 500: 1,321.12 Change: +0.30%
Zacks_Analysts
At least 5 active picks are required to calculate a P&P score.

Zacks_Analysts' Blog : CDC Software Files IPO - Analyst Blog

Date July 16, 2009    Comments Comments (0)    Rate this post Recommend This Post (27)   
Bookmark and Share
Abuse this post  Report Abuse
Please report this as abuse only if you believe it violates People And Picks  Terms of Use
You must log in to send an abuse report.
Share ThisShare This
Free Options Trader Guide


Today, CDC Corporation (CHINA) announced that CDC Software, a wholly-owned subsidiary has filed a registration statement with the SEC for an initial public offering (IPO) of 4.8 million American depositary shares (ADS) at an estimated price of $11.0- $13.0 range.

 

Of this total, 4 million ADS will represent newly-issued Class A ordinary shares being offered for sale by CDC Software and 0.8 million will represent Class A ordinary shares by CDC Software International Corporation, a wholly-owned subsidiary of CDC.

 

CDC expects to raise $43.4 million proceeds from the IPO and CDC Software International would receive net proceeds of $8.7 million. Thus the company expects to raise total proceeds of approximately $52.1 million from the IPO, assuming an IPO price per ADS of $12.00.

 

The offering will allow CDC Software to differentiate its line of business from CDC Corporation and expand sales channels, fund research and development activities and continue with its acquisition strategy. If executed, CDC Software will trade separately under the symbol ‘CDCS’ with the parent company being the major holder.

 

This IPO will help CDC Software achieve company-wide integration of business and technical information across multiple divisions and organizational boundaries. It will also help expand into other verticals and emerging markets such as India and China.

 

Post-IPO, CDC Corporation’s equity interest in CDC Software will be reduced from 100% to 83.4%, while CDC Corporation’s voting interests in CDC Software will be reduced from 100% to 98.1%. Lazard Capital Markets and JMP Securities are acting as underwrites in the deal.

 

We maintain our Buy rating on CDC’s shares.
Read the full analyst report on "CHINA"
Zacks Investment Research
Tags : CDC   CHINA   SEC   IPO   ADS   CDCS   JMP  

Want to comment on this post? Sign up now. It's FREE!
Already registered? Log In.
Sponsored Links